Top Story

Recently

arizona-psychedelics-conference

This is what psychedelic mainstreaming looks like…in Arizona

David Nickles
Feb 4
As psychedelic medicalization and the potential profits of a “virgin market” loom large, new organizations are increasingly looking to gain legitimacy within the field. Mainstreaming means the doors of this field are being thrown wide open.

Top Story

Recently

arizona-psychedelics-conference

This is what psychedelic mainstreaming looks like…in Arizona

David Nickles
Feb 4
As psychedelic medicalization and the potential profits of a “virgin market” loom large, new organizations are increasingly looking to gain legitimacy within the field. Mainstreaming means the doors of this field are being thrown wide open.

Join Expand in Spain, July 6-12, 2019

Register Today

Popular Reads

future-of-mdma

The Future of MDMA: Phase 3 and Beyond

Russell Hausfeld
What does the future hold for MDMA? We explore MAPS' ongoing FDA phase 3 clinical trials, rescheduling, health insurance, and expanded access. 
Its-time-to-debunk-prohibitionist-narratives-and-calls-for-monopolies-within-psychedelic-science-2

It’s time to debunk prohibitionist narratives and calls for monopolies within psychedelic science

David Nickles
As venture-capital-backed, for-profit companies barrel into psychedelic therapy, the potential for the widespread privatization of psychedelic knowledge and profits looms large. Some researchers are so enthusiastic about medicalization by “any means necessary” that they’re resorting to prohibitionist historical narratives and calling for monopolies to push the agenda forward.
PSYCHEDELIC
SISTERS IN ARMS

A series of personal stories on consent, gender, and sexual violence
against women in psychedelic communities

Read the series
PSYCHEDELIC
SISTERS IN ARMS

A series of personal stories on consent, gender, and sexual violence against women in psychedelic communities

Read the series

Popular Reads

future-of-mdma

The Future of MDMA: Phase 3 and Beyond

Russell Hausfeld
What does the future hold for MDMA? We explore MAPS' ongoing FDA phase 3 clinical trials, rescheduling, health insurance, and expanded access. 
Its-time-to-debunk-prohibitionist-narratives-and-calls-for-monopolies-within-psychedelic-science-2

It’s time to debunk prohibitionist narratives and calls for monopolies within psychedelic science

David Nickles
As venture-capital-backed, for-profit companies barrel into psychedelic therapy, the potential for the widespread privatization of psychedelic knowledge and profits looms large. Some researchers are so enthusiastic about medicalization by “any means necessary” that they’re resorting to prohibitionist historical narratives and calling for monopolies to push the agenda forward.
THE IBOGAINE
CONVERSATION

A multi-part series, explores everything from iboga’s traditional Bwiti use
in Gabon, Africa, to its ability to treat opioid addiction and withdrawal,
to its safety and very real risks.

Read the conversation
THE IBOGAINE
CONVERSATION

A multi-part series, explores everything from iboga’s traditional Bwiti use in Gabon, Africa, to its ability to treat opioid addiction and withdrawal, to its safety and very real risks.

Read the conversation
THE PSYCHEDELIC
DIVERSITY CONVERSATION

The Psychedelic Community needs more diversity. Let’s talk about that. 

Read the conversation
THE PSYCHEDELIC
DIVERSITY CONVERSATION

The Psychedelic Community needs more diversity. Let’s talk about that.

Read the conversation
COMING 
OUT OF THE
PSYCHEDELIC CLOSET

The decades-long “War on Drugs” has created a situation in which the use
of psychedelics is a social justice issue.

Read the conversation
COMING 
OUT OF THE
PSYCHEDELIC CLOSET

The decades-long “War on Drugs” has created a situation in which the use of psychedelics is a social justice issue.

Read the conversation